Contracts › 75F40123F80143
75F40123F80143: Cder Streamline Process and Enhance Functions for New Drug Review
Awarded to Agisol Llc by Food and Drug Administration (FDA).
$3.0Mobligated
$4.1Mpotential value
31 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40123F80143 |
|---|---|
| Vehicle | 47QTCA18D0071 |
| Awardee | Agisol Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541519 Other Computer Related Services |
| PSC | B537 Special Studies/Analysis- Medical/Health |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 08 June 2023 to 31 July 2027 |
| Potential end | 31 July 2028 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541519 contracts · All expiring contracts · USASpending record